LINCOPECT is a synergistic combination of
lincomycin and spectinomycin. Spectinomycin
primarily targets Gram-negative bacteria such
as E. coli, Salmonella spp., Campylobacter,
and Mycoplasma, acting bacteriostatically or
bactericidally depending on the dose. Lincomycin
acts mainly on Gram-positive bacteria such
as Staphylococcus spp., Streptococcus spp.,
Treponema spp., and Mycoplasma. Together, they
provide broad-spectrum coverage for poultry
infections.